To obtain further information on the prescribing pattern and therapeutic long term value in patients suffering from moderate or severs Chronic Obstructive Pulmonary Disease under conditions of daily practice
Study Type
OBSERVATIONAL
Enrollment
105
Change in overall severity of the clinical picture rated on a 4-point scale
Time frame: Up to 6 months after first study drug administration
Investigator assessment of improvement of thec linical picture rated on a 6-point symptom profile
Time frame: Up to 6 months after first study drug administration
Assessment of efficacy by investigator on a 4-point scale
Time frame: Up to 6 months after first study drug administration
Assessment of efficacy by patient on a 4-point scale
Time frame: Up to 6 months after first study drug administration
Assessment of tolerability by investigator on a 4-point scale
Time frame: Up to 6 months after first study drug administration
Assessment of tolerability by patient on a 4-point scale
Time frame: Up to 6 months after first study drug administration
Number of patients with adverse drug reactions
Time frame: Up to 6 months after first study drug administration
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.